Curatis Holding AG Approves All Board Proposals at AGM

On May 22, 2026, Curatis Holding AG, a specialty pharmaceutical company listed on the SIX Swiss Exchange, held its Annual General Meeting in Liestal, Switzerland. The meeting witnessed the approval of all proposals presented by the Board of Directors. This encompassed resolutions connected to the 2025 annual report and financial statements.

A significant 80.97% of voting rights were represented at the meeting. Shareholders gave their consent for another term for board members, including Chairman Marian Borovsky, and members Günter Graubach, Roland Rutschmann, and Silvio Inderbitzin.

Additionally, the AGM saw the re-election of the compensation committee comprising Borovsky, Rutschmann, and Graubach. The shareholders also approved the re-election of the auditor, Forvis Mazars. These decisions underline the shareholders' confidence in the company's leadership and strategic direction.